In both in vitro and in vivo models of PD curcumin could prevent oxidative stress toxicity by reducing the production of ROS and malondialdehyde and restoring GSH levels [123,124,125] which shields against alpha-synuclein-induced toxicity in the brain [123]. The gene discussed is SNCA; the disease is Parkinson disease.